Identification of new targets and drug development necessitates close collaborations between clinicians, scientists at academic centers, CRO’s and Biopharma.
We are committed to collaborate with scientists worldwide to help for the go/no go decision for clinical evaluation, to identify the right biomarkers and indication(s).
4HF Biotec is committed to being a partner to biotech and the pharmaceutical industry to help at early stage drug discovery, e.g. target identification and understanding target pathway in the disease.
If your aim is the development of innovative therapeutics for treating cancer we are pleased to discuss opportunities of partnering.